https://www.pharmaceutical-technology.com/data-insights/mesenchymal-stromal-cell-therapy-orbsen-therapeutics-lupus-nephritis-likelihood-of-approval/
Mesenchymal Stromal Cell Therapy is under clinical development by Orbsen Therapeutics and currently in Phase II for Lupus Nephritis.
mesenchymal stromal celllupus nephritistherapyorbsentherapeutics